SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
head and neck cancer
Journals
18
1
PloS one
2
Journal of enzyme inhibition and medicinal chemistry
3
plos medicine
4
BMJ open
5
Trials
6
Frontiers in immunology
7
cancer
8
ethnicity & health
9
european journal of immunology
10
endocrine practice : official journal of the american college of endocrinology and the american association of clinical endocrinologists
11
the laryngoscope
12
cancer letters
13
annals of clinical and laboratory science
14
oral and maxillofacial surgery clinics of north america
15
Journal of medical imaging and radiation oncology
16
oral oncology
17
dysphagia
18
neuroimaging clinics of north america
Research Groups
0
No Research Group Connected
Bibliographies
95
1
Patients' Perspectives on What Makes a Better Care Experience While Undergoing Treatment for Oropharyngeal Dysphagia Secondary to Head and Neck Cancer.
2
Self-care for head and neck cancer survivors with lymphedema and fibrosis: study protocol for a randomized controlled trial.
3
Finding/identifying primaries with neck disease (FIND) clinical trial protocol: a study integrating transoral robotic surgery, histopathological localisation and tailored deintensification of radiotherapy for unknown primary and small oropharyngeal head and neck squamous cell carcinoma.
4
Chemotherapy in the definitive management of oral cancers: Where do we stand today?
5
Outcomes of curative (chemo)radiotherapy for patients with non-p16 positive head and neck squamous cell carcinoma who are borderline for curative treatment.
6
Effectiveness of a guided self-help exercise program tailored to patients treated with total laryngectomy: Results of a multi-center randomized controlled trial.
7
Factors associated with HIV testing among young females; further analysis of the 2016 Ethiopian demographic and health survey data.
8
A financial incentive program to improve appointment attendance at a safety-net hospital-based primary care hepatitis C treatment program.
9
A multicomponent secondary school health promotion intervention and adolescent health: An extension of the SEHER cluster randomised controlled trial in Bihar, India.
10
SECONDARY AMENORRHOEA AS PRIMARY PRESENTATION OF IDIOPATHIC INTRACRANIAL HYPERTENSION.
11
TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies.
12
Safe management of laryngectomized patients during the COVID-19 pandemic.
13
CD8+CD73+ T cells in the tumor microenvironment of head and neck cancer patients are linked to diminished T cell infiltration and activation in tumor tissue.
14
HPV-Associated Head and Neck Cancer: Molecular and Nano-Scale Markers for Prognosis and Therapeutic Stratification
15
Machine Learning Applications for Head and Neck Imaging.
16
low-dose vs. high-dose cisplatin: lessons learned from 59 chemoradiotherapy trials in head and neck cancer
17
second primary cancer in patients with head and neck squamous cell carcinoma: case report
18
a comparison of psychological well-being and quality of life between spouse and non-spouse caregivers in patients with head and neck cancer: a 6-month follow-up study
19
(−)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo
20
targeting head and neck cancer by vaccination
21
palliative benefits of the multimodality approach in the re-treatment of recurrent malignant glioma: two case reports
22
anti pd-l1 durvalumab combined with cetuximab and radiotherapy in locally advanced squamous cell carcinoma of the head and neck: a phase i/ii study (ducro)
23
management of ramsay hunt syndrome in an acute palliative care setting
24
skull base or cervical vertebral osteomyelitis following chemoradiotherapy for pharyngeal carcinoma: a serious but treatable complication
25
hla typing in taiwanese patients with oral squamous cell carcinoma
26
radiofrequency ablation of sphenopalatine ganglion for head and neck cancer pain management
27
self-image of the patients with head and neck cancer: a mixed method research
28
pericardial metastasis from p16 positive oropharyngeal squamous cell carcinoma
29
impact and prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography scan in the evaluation of residual head and neck cancer: single-center experience from pakistan
30
a technology developed from concept of acupuncture and meridian system, the clinical effect of bioceramic resonance on psychological related sleep disturbance with findings on questionnaire, eeg and fmri
31
spiritual needs of cancer patients: a qualitative study
32
Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis
33
Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer.
34
Correlation of Diffusion-weighted MR imaging and FDG PET/CT in the Diagnosis of Metastatic Lymph Nodes of Head and Neck Malignant Tumors
35
Spatial analysis identifies DC niches as predictors of pembrolizumab therapy in head and neck squamous cell cancer.
36
Exposed Necrotic Bone in a Head and Neck Cancer Patient: Report of a Diagnostic Challenge.
37
Associations between substance use, quality of life, and pain among Veteran survivors of head and neck cancer.
38
Preoperative Neoadjuvant Chemotherapy or Immunotherapy in Head and Neck Cancer: A Systematic Review and Meta-Analysis of Surgical Risk and Pathologic Response.
39
Targeted gold nanoparticles enable molecular CT imaging of head and neck cancer: An in vivo study.
40
Factors driving frequent attendance at emergency departments for patients with head and neck cancer.
41
Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: The NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank
42
Understanding cognitive and emotional illness representations of South Asian head and neck cancer survivors: a qualitative study.
43
Advances in Functional Imaging in the Assessment of Head and Neck Cancer.
44
Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.
45
Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns.
46
Do CO and oxidative stress induce cancer?: a brief study about the evaluation of PON 1, CAT, CA and XO enzyme levels on head and neck cancer patients.
47
Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
48
Erratum: Safety standards for invasive procedures in out-patient departments, managing subglottic stenosis in pregnancy, a critical review on follow up of head and neck cancer patients, and a new classification for cochleovestibular malformations (Journal of Laryngology and Otology (2019) 133:5 (355-355) DOI: 10.1017/S0022215119001129)
49
Quality of Care Indicators for Head and Neck Cancers: The Experience of the European Project RARECAREnet.
50
Dosimetric and Monte Carlo verification of jaws-only IMRT plans calculated by the Collapsed Cone Convolution algorithm for head and neck cancers.
51
Resources for dysphagia. Dietary adaptations in head and neck cancer
52
Pacientes afectos de neoplasia de cabeza-cuello con nutrición enteral domiciliaria por sonda Head and neck cancer patients included at home enteral nutrition by tube
53
A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer
54
Comparison of Head and Neck Cancer Distribution in Turkish and Syrian Populations.
55
Effect of True and Sham Acupuncture on Radiation-Induced Xerostomia Among Patients With Head and Neck Cancer: A Randomized Clinical Trial
56
Palliative chemotherapy in head and neck cancer: balancing between beneficial and adverse effects.
57
Welding and the risk of head and neck cancer: the ICARE study.
58
CXCL11-CXCR3 axis mediates tumor lymphatic crosstalk and inflammation induced tumor promoting pathways in head and neck cancers.
59
Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck cancer: A case series follow-up study.
60
Quality of life of head and neck cancer patients in urban and regional areas: An Australian perspective
61
Quality of life of patients from rural and urban areas in Poland with head and neck cancer treated with radiotherapy. A study of the influence of selected socio-demographic factors
62
Gefitinib and afatinib show potential efficacy for Fanconi anemia-related head and neck cancer.
63
NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy
64
Global frequency and distribution of head and neck cancer in pediatrics, a systematic review.
65
Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic.
66
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.
67
Rapid implementation of an evidence-based remote triaging system for assessment of suspected head and neck cancer referrals and patients on follow up after treatment during the COVID-19 pandemic: A model for international collaboration.
68
Implementation of meta-analysis approach, comparing conventional radiotherapy, and proton beam therapy treating head and neck cancer
69
Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients
70
Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients
71
Quality of life of head and neck cancer patients before and after cancer-directed treatment – A longitudinal study
72
Implementation of meta-analysis approach, comparing conventional radiotherapy, and proton beam therapy treating head and neck cancer
73
Quality of life of head and neck cancer patients before and after cancer-directed treatment - A longitudinal study
74
Randomised, double-blind, placebo-controlled trial of oral probiotic Streptococcus salivarius M18 on head and neck cancer patients post-radiotherapy: a pilot study
75
evaluation of oral health status and quality of life of head and neck cancer patients after radiation therapy
76
pharmacokinetics of sublingually delivered fentanyl in head and neck cancer patients treated with curatively aimed chemo or bioradiotherapy
77
profiling the behavior of distinct populations of head and neck cancer stem cells
78
recent advances in chemotherapy for head and neck cancers
79
survival of dental implants in native and grafted bone in irradiated head and neck cancer patients: a retrospective analysis
80
cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatment
81
cancer stem cells in head and neck cancer
82
biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells
83
cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials
84
the tip of the iceberg: clinical implications of genomic sequencing projects in head and neck cancer
85
epidemiological aspects of head and neck cancers in a population of south east region of iran
86
proteomic study of hpv-positive head and neck cancers: preliminary results
87
head and neck cancer in hiv patients and their parents: a danish cohort study
88
the role of hpv in head and neck cancer stem cell formation and tumorigenesis
89
t cell-tumor interaction directs the development of immunotherapies in head and neck cancer
90
anti-tumor immunity in head and neck cancer: understanding the evidence, how tumors escape and immunotherapeutic approaches
91
il-6 inhibition with medi5117 decreases the fraction of head and neck cancer stem cells and prevents tumor recurrence
92
qualidade de vida de pacientes com carcinoma em cabeça e pescoço quality of life of patients with head and neck cancer
93
a review of scientific papers about head and neck cancers
94
Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature
95
Impact of repeat computerized tomography replans in the radiation therapy of head and neck cancers